Literature DB >> 15217412

Augmentation of T-cell apoptosis by immunosuppressive agents.

K Takahashi1, M Reynolds, N Ogawa, D L Longo, J Burdick.   

Abstract

The regulatory benefit of apoptosis (activation-induced cell death, AICD) in T cells can be influenced by immunosuppressive agents. We examined this for mycophenolate mofetile (MMF, using it's active metabolite, mycophenolate (MPA)) compared with rapamycin (RAPA) and the calcineurin inhibitors (CI) cyclosporin (CYA) and FK506 (FK). Pure T cells from peripheral blood leucocytes (PBL) were stimulated by anti-CD3 plus anti-CD28. Cell division (sequential cohort reduction in carboxyflourescein diacetate succinimidyl ester, CFSE) was used to measure proliferation and determine status of different cell generations without or with added drug at 4 d. Apoptosis was measured by Annexin V staining of activated cells using flow cytometry. We confirmed in this stringent system the inhibition of AICD by CI and showed that RAPA is intermediate and MPA most effective in this potentiation of AICD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15217412     DOI: 10.1111/j.1399-0012.2004.00222.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  6 in total

1.  Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated mice.

Authors:  Robyn E Mills; Kristen R Taylor; Katie Podshivalova; Dianne B McKay; Julie M Jameson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 2.  Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.

Authors:  Agnes Hackl; Rasmus Ehren; Lutz Thorsten Weber
Journal:  Pediatr Nephrol       Date:  2016-06-16       Impact factor: 3.714

3.  The Pim kinases control rapamycin-resistant T cell survival and activation.

Authors:  Casey J Fox; Peter S Hammerman; Craig B Thompson
Journal:  J Exp Med       Date:  2005-01-10       Impact factor: 14.307

4.  Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.

Authors:  L E Perez; H Fernandez; E Ayala; F Beato; A Neuger; J Pidala; M J Schell; C Anasetti
Journal:  Bone Marrow Transplant       Date:  2016-12-19       Impact factor: 5.483

5.  Incidence and Impacts of Inflammatory Bowel Diseases among Kidney Transplant Recipients: A Meta-Analysis.

Authors:  Panupong Hansrivijit; Max M Puthenpura; Charat Thongprayoon; Himmat S Brar; Tarun Bathini; Karthik Kovvuru; Swetha R Kanduri; Karn Wijarnpreecha; Wisit Cheungpasitporn
Journal:  Med Sci (Basel)       Date:  2020-09-16

6.  In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine Lymphocytes.

Authors:  Maciej Guzera; Lidia Szulc-Dąbrowska; Anna Cywińska; Joy Archer; Anna Winnicka
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.